Business lines
MAS offers the following products:
- Diagnostic, nutri- and pharmacogenetic and therapeutic intellectual property (IP) for out-licensing
- Services in:
- validation of genetic and proteomics discoveries and diagnostic, pharmacogenetic and prognostic biomarkers and therapeutic targets,
- clinical trial planning, execution and analysis, and
- consultation in clinical medical care and health care programs focusing on the field of cardiovascular and metabolic diseases, such as coronary heart disease (CHD), type 2 diabetes and obesity. MAS licenses IP to diagnostic, nutritional, biotechnology and therapeutic companies and has service income from genotyping, data and biobank access and clinical trial and medical services. Upon investment, MAS will initiate drug target validation and possibly drug development programs in CHD, obesity and T2D.
